PubMed=22052944; DOI=10.1242/dmm.008409; PMCID=PMC3291643
Lahti A.L., Kujala V.J., Chapman H., Koivisto A.-P., Pekkanen-Mattila M., Kerkela E., Hyttinen J.A.K., Kontula K., Swan H., Conklin B.R., Yamanaka S., Silvennoinen O., Aalto-Setala K.
Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell culture.
Dis. Model. Mech. 5:220-230(2012)

PubMed=22315618; DOI=10.1155/2012/875059; PMCID=PMC3270482
Pekkanen-Mattila M., Ojala M., Kerkela E., Rajala K., Skottman H., Aalto-Setala K.
The effect of human and mouse fibroblast feeder cells on cardiac differentiation of human pluripotent stem cells.
Stem Cells Int. 2012:875059.1-875059.10(2012)

PubMed=22962621; DOI=10.1371/journal.pone.0044660; PMCID=PMC3433449
Kujala K., Paavola J., Lahti A.L., Larsson K., Pekkanen-Mattila M., Viitasalo M., Lahtinen A.M., Toivonen L., Kontula K., Swan H., Laine M., Silvennoinen O., Aalto-Setala K.
Cell model of catecholaminergic polymorphic ventricular tachycardia reveals early and delayed afterdepolarizations.
PLoS ONE 7:E44660-E44660(2012)

PubMed=23119085; DOI=10.1371/journal.pone.0048659; PMCID=PMC3485380
Ojala M., Rajala K., Pekkanen-Mattila M., Miettinen M., Huhtala H., Aalto-Setala K.
Culture conditions affect cardiac differentiation potential of human pluripotent stem cells.
PLoS ONE 7:E48659-E48659(2012)

PubMed=23341440; DOI=10.5966/sctm.2012-0047; PMCID=PMC3659749
Toivonen S., Ojala M., Hyysalo A., Ilmarinen T., Rajala K., Pekkanen-Mattila M., Aanismaa R., Lundin K., Palgi J., Weltner J., Trokovic R., Silvennoinen O., Skottman H., Narkilahti S., Aalto-Setala K., Otonkoski T.
Comparative analysis of targeted differentiation of human induced pluripotent stem cells (hiPSCs) and human embryonic stem cells reveals variability associated with incomplete transgene silencing in retrovirally derived hiPSC lines.
Stem Cells Transl. Med. 2:83-93(2013)

PubMed=27026928; DOI=10.1186/s40064-016-1889-y; PMCID=PMC4771667
Kuusela J., Kujala V.J., Kiviaho A.L., Ojala M., Swan H., Kontula K., Aalto-Setala K.
Effects of cardioactive drugs on human induced pluripotent stem cell derived long QT syndrome cardiomyocytes.
SpringerPlus 5:234.1-234.13(2016)